期刊文献+

缺血预适应对PTCA术后心肌肌钙蛋白I升高的影响 被引量:2

Beneficial impact of preconditioning during PTCA on cardiac troponin I release
下载PDF
导出
摘要 目的 用血清心肌肌钙蛋白I(cTnI)作为心肌损伤标记物评价缺血预适应 (IP)对经皮腔内冠状动脉成形术 (PTCA)心肌损伤的保护作用。方法 把 15 0例行PTCA的冠心病 (CAD)患者随机分为两组 :(1)常规手术组 (UC组 ) 12 0例 ;(2 )缺血预适应组 (设置缺血预适应手术方式 ,IP组 ) 30例。两组分别测定其术前、术后第 6、12、2 4、4 8、72小时的血清cTnI水平并进行随访 ,分析相关因素 ,比较两组间cTnI的变化及出院后发生的心脏事件。结果 UC组 12 0例患者中 2 9例术后cTnI升高 ,IP组 30例患者中 2例术后cTnI升高 ,两组cTnI升高差异有显著性 (P <0 0 5 ) ;随访发现发生的心脏事件两组间差异无显著性 (P >0 0 5 )。结论 缺血预适应对PTCA术造成的心肌损伤有保护作用 ,现尚不能肯定IP对PTCA术后患者心脏事件有影响。 Objective To evaluate protective function of ischemia preconditioning for myocardium during percutaneous transluminal coronary angioplasty (PTCA), using cardiac troponin I (cTnI) as myocardial injury marker. Methods One hundred and fifty patients with coronary artery disease (CAD) undergoing PTCA were divided into two groups: Group Usual Cure (G-UC), including 120 cases, and Group Ischemia Precondition (G-IP), including 30 cases. Serum cTnI were measured before and 6, 12, 24, 48 and 72 hours after the procedure respectively. The relative factors were analyzed. The cardiac events were followed-up.Results The serum cTnI levels of 29 cases elevated in G-UC, while those of 2 cases elevated in G-IP. There was statistical difference on elevated cTnI levels between the two groups (P<0.05). In the follow-up, occurrence of cardiac events was not statistically different in the two groups. Conclusion Ischemia preconditioning may protect myocardium dueing PTCA. Now it can not be sured that IP has impact on cardiac events in cases after PTCA.
出处 《中国介入心脏病学杂志》 2004年第1期9-11,共3页 Chinese Journal of Interventional Cardiology
关键词 缺血预适应 PTCA 心肌肌钙蛋白I 心肌损伤 冠心病 Ischemic preconditioning Cardiac troponin Angioplasty, transluminal, percutaneous coronary
  • 相关文献

参考文献1

二级参考文献2

共引文献18

同被引文献13

  • 1吴文利,梅霞,罗羽慧.尼可地尔治疗冠心病稳定型心绞痛68例[J].中国药业,2005,14(5):65-66. 被引量:13
  • 2马晓静,张兴华,罗曼,李春梅,邵建华.缺血预适应与缺血后适应现象对急性心肌梗死急症介入治疗后的影响[J].中华医学杂志,2007,87(2):114-117. 被引量:19
  • 3王树岩,陈瑾,杨新春,池洪杰,刘秀兰.再灌注心律失常对急性心肌梗死患者心肌细胞凋亡和左室重构的影响[J].中华心血管病杂志,2007,35(1):59-62. 被引量:12
  • 4Ikeda N, Yasu T, Kubo N, et al. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial in- farction[ J]. Heart,2004;90(2) :181-5.
  • 5Marry CE, Jennings RB, Reimer KA. Preconditioning with ischemia:a de- lay of lethal cell injury in ischemic myocardium[ J]. Circulation,1986 ;74 (5) :1124-36.
  • 6Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[ J]. Am J Physiol Heart Circ Physiol, 2003 ; 285 ( 2 ) :H579-88.
  • 7Ishii H, Ichimiya S, Kanashiro M, et al. Effect of intravenous nicorandil and preexisting angina pectoris on short-and long-term outcomes in pa- tients with a first ST-segment elevation acute myocardial infarction[J].Am J Cardio1,2007 ;99 (9) : 1203-7.
  • 8Toyama T, Seki R, Hoshizaki H, et al. Nicorandil administration shows cardioprotective effects in patients with poor TIMI and collateral flow as well as good flow after AMI[ J]. Ann Nucl Med,2006 ;20(4) :277-85.
  • 9Isono T, Kamihata H, Sutani Y, et al. Nicorandil suppressed myocardial injury after percutaneous coronary intervention [ J ]. Int J Cardiol, 2008 ; 123(2) :123-8.
  • 10Ota S, Nishikawa H, Takeuchi M, et al. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Muhicenter Angioplasty Revascularization Trial (SMART) [ J]. Circ J,2006;70(9) :1099-104.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部